Abstract
Accelerated heavy ions (3He, 12C, among others) nowadays provide an advanced non-invasive procedure for radiotherapy of tumors with risky or impossible access, henceforth called Hadron Cancer Therapy (Kraft 1990), (Durante 2008). Moreover heavy-ion beams naturally optimize the physical depth-dose profile (known as Bragg curve) with an increased relative biological efficiency in the target volume that as a consequence minimizes damage in the healthy tissue. A further advantage of heavy ions over protons is the positron production from a by-product of nuclear reactions and subsequent decays (Pshenichnov et al. 2005), (Pshenichnov et al. 2006). Thus positron emission tomography (PET) allows for dose verification in real-time. The raster-scan technology was developed at the GSI facility (Gademann et al. 1990), (Kraft et al. 1991) and today is, and in the close future will be implemented in several cancer treatment centers all over Europe. While treatment planning in the pioneer stage of the developments was done by experiments with phantoms, in the consolidation phase these may be substituted by computerized treatment planning engines that make use of physical and radio-biological data obtained at GSI and other places. The state of the art so far permits us to treat skull base tumors and tumors close to the spinal chord (Debus et al. 2000), (Durante and Loeffler 2010), (Schardt et al. 2010).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Agostinelli, S., Allison, J., Amako, K. et al.: GEANT4—a simulation toolkit. Nucl. Instr. Meth. Phys. Res. A, 506, 250–303 (2003).
Allison, J. et al.: Geant developments and applications. IEEE Trans. Nucl. Sci., 53, n. 1, Part 2, 270–278 (2006).
Cygler, J.E., Lochrin, C., Daskalov, G.M., Howard, M., Zohr, R., Esche, B., Eapen, L., Grimard, L., Caudrelier, J.M.: Clinical use of a commercial Monte Carlo treatment planning system for electron beams. Phys. Med. Biol., 50, 1029–1034 (2005).
Debus, J., Haberer, T., Schulze-Ertner, D., Jäkel, O., Wenz, F., Enghardt, W., Schlegel, W., Kraft, G., Wannenmacher, M.: Fractionated carbon ion irradiation of skull base tumors at GSI. First clinical results and future perspectives. Strahlenther. Onkol., 176, 211–216 (2000).
Ding, M., Li, J., Deng, J., Fourkai, E., Ma, C.-M.: Dose correlation for thoracic motion in radiation therapy of breast cancer. Med. Phys., 30, 2520–2529 (2003).
Durante, M.: Focus on heavy ions in biophysics and medical physics. New J. Phys., 10, 075002 (2008).
Durante, M., Loeffler, J.S.: Charged particles in radiation oncology. Nat. Rev. Clin. Oncol., 7, 37–43 (2010).
Fraass, B.A., Smathers, J., Deye, J.: Summary and recommendations of a National Cancer Institute workshop on issues limiting the clinical use of Monte Carlo calculation algorithms for megavoltage external beam radiation therapy. Med. Phys., 30, 3206–3216 (2003).
Gademann, G., Hartmann, G.H., Kraft, G., Lorenz, W.-J., Wannenmacher M.: The medical heavy ion therapy project at the Gesellschaft für Schwerionenforschung facility in Darmstadt. Strahlenther. Onkol., 166, 34–39 (1990).
Jeraj, R., Keall, P.J., Siebers, J.V.: The effect of dose calculation accuracy on inverse treatment planning. Phys. Med. Biol., 47, 391–407 (2002).
Keall, P.J., Siebers, J.V., Arnfield, M., Kim, J.O., Mohan, R.: Monte Carlo dose calculations for dynamic IMRT treatments. Phys. Med. Biol., 46, 929–941 (2001).
Kraft, G.: Radiobiological and physical basis for radiotherapy with protons and heavier ions. Strahlenther. Onkol., 166, 10–13 (1990).
Kraft, G., Becher, W., Blasche, K., Böhne, D., Fischer, B., Gademann, G., Geissel, H., Haberer, Th., Klabunde, J., Kraft-Weyrather, W., Langenbeck, B., Mänzenberg, G., Ritter, S., Rösch, W., Schardt, D., Stelzer, H., Schwab, Th.: The heavy ion therapy project at GSI. Nucl. Tracks Radiat. Meas., 19, 911 (1991).
Kraft, G.: Heavy-ion therapy at GSI. Europhys. News, 25, n. 4, 81 (1994).
Kraft, G., Arndt, U., Becher, W., Schardt, D., Stelzer, H., Weber, U.: Heavy ion therapy at GSI. Th. Archinal Nucl. Instr. and Meth. in Phys. Res. A, 367, 66 (1995).
Liu, H.H., Verhaegen, F., Dong, L.: A method of simulating dynamic multileaf collimators using Monte Carlo techniques for intensity-modulated radiation therapy. Phys. Med. Biol., 46, 2283–2289 (2001).
Mohan, R., Antolak, J., Hendee, W.R.: Monte Carlo techniques should replace analytical methods for estimating dose distributions in radiotherapy treatment planning. Med. Phys., 28, 123–126 (2001).
Pshenichnov, I.A., Mishustin, I.N., Greiner, W.: Neutrons from fragmentation of light nuclei in tissue-like media: a study with GEANT4 toolkit. Phys. Med. Biol., 50, 5493–5507 (2005).
Pshenichnov, I.A., Mishustin, I.N., Greiner, W.: Distributions of positron-emitting nuclei in proton and carbon-ion therapy studied with GEANT4. Phys. Med. Biol., 51, 6099–6112 (2006).
Schardt, D., Elsässer, T., Schulz-Ertner, D.: Heavy-ion tumor therapy: physical and radiobiological benefits. Rev. Mod. Phys., 82, 383–425 (2010).
Verhaegen, F., Liu, H.H.: Incorporating dynamic collimator motion in Monte Carlo simulations: an application in modelling a dynamic wedge. Phys. Med. Biol., 46, 287–296 (2001).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Burigo, L.N., Hadjimichef, D., Bodmann, B.E.J. (2011). A Self-Consistent Monte Carlo Validation Procedure for Hadron Cancer Therapy Simulation. In: Constanda, C., Harris, P. (eds) Integral Methods in Science and Engineering. Birkhäuser Boston. https://doi.org/10.1007/978-0-8176-8238-5_3
Download citation
DOI: https://doi.org/10.1007/978-0-8176-8238-5_3
Publisher Name: Birkhäuser Boston
Print ISBN: 978-0-8176-8237-8
Online ISBN: 978-0-8176-8238-5
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)